Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S
Open accessPublished version of a preprint
The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To combine prospective cohort studies, by including HLA harmonization, and estimate risk of islet autoimmunity and progression to clinical diabetes. RESEARCH DESIGN AND METHODS: For prospective cohorts in Finland, Germany, Sweden, and the U.S., 24,662 children at increased genetic risk for development of islet autoantibodies and type 1 diabetes have been followed. Following harmonization, the outcomes were analyzed in 16,709 infants-toddlers enrolled by age 2.5 years. RESULTS: In the infant-toddler cohort, 1,413 (8.5%) developed at least one autoantibody confirmed at two or more consecutive visits (seroconversion), 865 (5%) developed multiple autoantibodies, and 655 (4%) progressed to diabetes. The 15-year cumulative incidence of diabetes varied in children with one, two, or three autoantibodies at seroconversion: 45% (95% CI 40–52), 85% (78–90), and 92% (85–97), respectively. Among those with a single autoantibody, status 2 years after seroconversion predicted diabetes risk: 12% (10–25) if reverting to autoantibody negative, 30% (20–40) if retaining a single autoantibody, and 82% (80–95) if developing multiple autoantibodies. HLA-DR-DQ affected the risk of confirmed seroconversion and progression to diabetes in children with stable single-autoantibody status. Their 15-year diabetes incidence for higher- versus lower-risk genotypes was 40% (28–50) vs. 12% (5–38). The rate of progression to diabetes was inversely related to age at development of multiple autoantibodies, ranging from 20% per year to 6% per year in children developing multipositivity in ≤2 years or >7.4 years, respectively. CONCLUSIONS: The number of islet autoantibodies at seroconversion reliably predicts 15-year type 1 diabetes risk. In children retaining a single autoantibody, HLA-DR-DQ genotypes can further refine risk of progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of multiple islet autoantibodies (IAA, GADA, IA-2A/IA-2bA, or ZnT8A) is associated with a risk of type 1 diabetes of >90% (408,422,423).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [423]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Self-citationInsel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216
Self-citationEpidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092
HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
Erlich, H., Valdes, A. M., Noble, J., Carlson, J. A., Varney, M., Concannon, P., Mychaleckyj, J. C., Todd, J. A., Bonella, P., Fear, A. L., et al. (2008) · Diabetes · doi:10.2337/db07-1331 · Cited by 790
Ziegler, A. G., Hummel, M., Schenker, M., & Bonifacio, E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 645
Self-citationthe TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3514-y · Cited by 444
Self-citationRewers, M., Bugawan, T. L., Norris, J. M., Blair, A., Beaty, B., Hoffman, M., McDuffie, R. S., Hamman, R. F., Klingensmith, G., Eisenbarth, G. S., et al. (1996) · Diabetologia · doi:10.1007/s001250050514 · Cited by 422
Self-citationDiabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Kupila, A., Muona, P., Simell, T., Arvilommi, P., Savolainen, H., Hämäläinen, A.-M., Korhonen, S., Kimpimäki, T., Sjöroos, M., Ilonen, J., et al. (2001) · Diabetologia · doi:10.1007/s001250051616 · Cited by 339
Self-citationIncidence of Type 1 Diabetes in Finland
Harjutsalo, V., Sund, R., Knip, M., & Groop, P.-H. (2013) · JAMA · doi:10.1001/jama.2013.8399 · Cited by 264
Self-citationHagopian, W. A., Erlich, H., Lernmark, Å., Rewers, M., Ziegler, A. G., Simell, O., Akolkar, B., Vogt, R., Blair, A., Ilonen, J., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00774.x · Cited by 260
Self-citationBlood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
Arif, S., Leete, P., Nguyen, V., Marks, K., Nor, N. M., Estorninho, M., Kronenberg-Versteeg, D., Bingley, P. J., Todd, J. A., Guy, C., et al. (2014) · Diabetes · doi:10.2337/db14-0365 · Cited by 238
Thirty Years of Prospective Nationwide Incidence of Childhood Type 1 Diabetes
Berhan, Y., Waernbaum, I., Lind, T., Möllsten, A., Dahlquist, G., & for the Swedish Childhood Diabetes Study Group* (2011) · Diabetes · doi:10.2337/db10-0813 · Cited by 237
Wenzlau, J. M., Liu, Y., Yu, L., Moua, O., Fowler, K. T., Rangasamy, S., Walters, J., Eisenbarth, G. S., Davidson, H. W., & Hutton, J. C. (2008) · Diabetes · doi:10.2337/db08-0522 · Cited by 205
Predicting Type 1 Diabetes Using Biomarkers
Bonifacio, E. (2015) · Diabetes Care · doi:10.2337/dc15-0101 · Cited by 191
Steck, A. K., Vehik, K., Bonifacio, E., Lernmark, A., Ziegler, A.-G., Hagopian, W. A., She, J., Simell, O., Akolkar, B., Krischer, J., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2426 · Cited by 185
Self-citationKlitz, W., Maiers, M., Spellman, S., Baxter‐Lowe, L. A., Schmeckpeper, B., Williams, T. M., & Fernandez‐Viña, M. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00103.x · Cited by 179
Vock, D. M., Wolfson, J. A., Bandyopadhyay, S., Adomavičius, G., Johnson, P. E., Vazquez‐Benitez, G., & O’Connor, P. J. (2016) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2016.03.009 · Cited by 154
Krischer, J. P., Liu, X., Lernmark, Å., Hagopian, W., Rewers, M., She, J., Toppari, J., Ziegler, A., Akolkar, B., & on behalf of the TEDDY Study Group (2017) · Diabetes · doi:10.2337/db17-0261 · Cited by 148
Self-citationIlonen, J., Reijonen, H., Herva, E., Sjöroos, M., Iitiä, A., Lövgren, T. N.-E., Veijola, R., Knip, M., Åkerblom, H. K., & The Childhood Diabetes in Finland (DIME) Study Group (1996) · Diabetes Care · doi:10.2337/diacare.19.8.795 · Cited by 137
Self-citationSiljander, H. T. A., Simell, S., Hekkala, A., Lähde, J., Simell, T., Vähäsalo, P., Veijola, R., Ilonen, J., Simell, O., & Knip, M. (2009) · Diabetes · doi:10.2337/db08-1305 · Cited by 132
Self-citationClustervision: Visual Supervision of Unsupervised Clustering
Kwon, B. C., Eysenbach, B., Verma, J., Ng, K., De Filippi, C., Stewart, W. F., & Perer, A. (2018) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2017.2745085 · Cited by 132
Self-citationThe European Nicotinamide Diabetes Intervention Trial (ENDIT) Group, Bingley, P. J., & Gale, E. A. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0160-4 · Cited by 121
Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study
Vehik, K., Lynch, K. F., Schatz, D. A., Akolkar, B., Hagopian, W., Rewers, M., She, J.-X., Simell, O., Toppari, J., Ziegler, A.-G., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0181 · Cited by 103
Self-citationLampasona, V., Pittman, D. L., Williams, A. J., Achenbach, P., Schlosser, M., Akolkar, B., Winter, W. E., Laboratories, P., Watson, K., Weets, I., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304196 · Cited by 103
Self-citationDPVis: Visual Analytics With Hidden Markov Models for Disease Progression Pathways
Kwon, B. C., Anand, V., Severson, K., Ghosh, S., Sun, Z., Frohnert, B. I., Lundgren, M., & Ng, K. (2020) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2020.2985689 · Cited by 82
Self-citationSalonen, K. M., Ryhänen, S. J., Härkönen, T., Ilonen, J., Knip, M., & Register, F. P. D. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2440 · Cited by 70
Self-citationNewborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates
Emery, L. M., Babu, S. R., Bugawan, T. L., Norris, J. M., Erlich, H. A., Eisenbarth, G. S., & Rewers, M. (2005) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2005.00117.x · Cited by 45
Self-citationWion, E. S., Brantley, M. S., STEVENS, J., GALLINGER, S., Peng, H., Glass, M., & Hagopian, W. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1288.067 · Cited by 44
Self-citationDysregulation of glucose metabolism in preclinical type 1 diabetes
Veijola, R., Koskinen, M. K., Helminen, O., & Hekkala, A. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12392 · Cited by 41
Self-citationA Swedish approach to the prevention of type 1 diabetes
Larsson, H. E. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12325 · Cited by 27
Clinical Research Informatics: Recent Advances and Future Directions
Dugas, M. (2015) · Yearbook of Medical Informatics · doi:10.15265/iy-2015-010 · Cited by 16
Characterizing Subgroups of Type 1 Diabetes
Skyler, J. S. (2014) · Diabetes · doi:10.2337/db14-1160 · Cited by 13
Koskinen, M. K., Lempainen, J., Löyttyniemi, E., Helminen, O., Hekkala, A., Härkönen, T., Kiviniemi, M., Simell, O., Knip, M., Ilonen, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02040 · Cited by 13
Self-citationModeling Disease Progression Trajectories from Longitudinal Observational Data
Kwon, B. C., Achenbach, P., Dunne, J. L., Hagopian, W., Lundgren, M., Ng, K., Veijola, R., Frohnert, B. I., Anand, V., & Group, T. T. S. (2020) · PubMed · doi:10.48550/arxiv.2012.05324 · Cited by 9
Self-citation
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Quattrin, T., Mastrandrea, L. D., & Walker, L. S. K. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00223-4 · Cited by 244
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 203
Besser, R. E. J., Bell, K. J., Couper, J., Ziegler, A., Wherrett, D. K., Knip, M., Speake, C., Casteels, K., Driscoll, K. A., Jacobsen, L. M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13410 · Cited by 188
Self-citationHaller, M. J., Bell, K. J., Besser, R. E. J., Casteels, K., Couper, J. J., Craig, M. E., Elding Larsson, H., Jacobsen, L., Lange, K., Oron, T., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000543035 · Cited by 151
Self-citation
Metadata
- Authors
- Anand, V., Li, Y., Liu, B., Ghalwash, M., Koski, E., Ng, K., Dunne, J. L., Jönsson, J., Winkler, C., Knip, M., Toppari, J., Ilonen, J., Killian, M. B., Frohnert, B. I., Lundgren, M., Ziegler, A.-G., Hagopian, W., Veijola, R., & Rewers, M.
- Affiliations
- IBM (United States) (US)
- Ain Shams University (EG)
- Breakthrough T1D (US)
- Lund University (SE)
- Helmholtz Munich (DE)
- University of Helsinki (FI)
- University of Turku (FI)
- Pacific Northwest Research Institute, Seattle, WA
- University of Colorado Denver (US)
- Oulu University Hospital (FI)
- Corresponding author
- Anand, Vibha
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-06-23
- Volume
- 44
- Issue
- 10
- Pages
- 2269-2276
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC8929180
- OpenAlex
- W3173682566
- Semantic Scholar
- e861f7aa2426d08c382e76e91205144bdbf4894e
- Cited by
- 83
- References
- 39
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 18 · 2023: 12 · 2022: 13 · 2021: 6
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion, other-oa)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK032493, R01DK026190, R37DK032493, R01DK104351, R37DK032083, P30DK116073, R01DK032083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- islet autoimmunity, islet autoantibodies, seroconversion, HLA markers, disease progression, diabetes risk prediction, children, infants and toddlers, genetic risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.